- 1. To compare the pharmacokinetics (PK) of Factor Eight Inhibitor Bypassing Activity (FEIBA component Factor II (FII) and safety of FEIBA reconstituted in a reduced volume of sterile water for injection (SWFI) versus regular volume SWFI, administered at the standard infusion rate of 2 U/min/kg